
JSP-1-SM + CAG
$65.00
Research blend of a GLP-1 receptor agonist and an amylin analog for dual-pathway metabolic signaling studies.
- Purity
- >99%
- Testing
- 3rd-party
- Shipping
- Tracked, discreet
Need the Certificate of Analysis for this batch? Request a COA.
About JSP-1-SM + CAG
Dual GLP-1 and amylin receptor co-activation blend. Complementary metabolic signaling research.
JSP-1-SM + CAG is a fixed-ratio research combination of JSP-1-SM, a long-acting GLP-1 receptor agonist, and Cagrilintide, a long-acting acylated amylin analog. The two components act through distinct receptor systems — GLP-1R on one side and amylin (AMY1-3) and calcitonin receptors on the other — that converge on overlapping central and peripheral metabolic pathways. This makes the pairing a useful model for studying how incretin and amylin signaling interact when engaged at the same time.
Research applications
- Dual GLP-1 receptor and amylin receptor co-agonism research
- Hypothalamic and brainstem satiety signaling pathway studies
- Glucagon suppression, gastric emptying, and glycemic regulation mechanisms
- Energy homeostasis and dual-mechanism metabolic signaling studies
- Fixed-ratio combination peptide pharmacokinetics research



